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Abstract
Background:  Primary mesothelioma of the pericardium comprises less than 1% of all
mesothelioma cases. Its typical presentation is insidious, with nonspecific signs and symptoms, and
usually results in heart failure due to cardiac tamponade, either by a serous effusion or by direct
tumorous constriction of the heart. With the exception of several case reports, the outcome is
uniformly fatal, and patients typically die within six months of diagnosis.
Case presentation: A 45-year-old African American female presented to the emergency
department with several days of dizziness, difficulty walking, and low blood pressure. The patient
suddenly suffered cardiac arrest, and her death was pronounced. The medical examiner assumed
jurisdiction of the case due to the sudden death nature of the case without known medical history.
At autopsy, a one-liter hemopericardium was present, and the pericardial sac was thick, granular
and adhesed to the heart, suspicious for pericarditis. Microscopic examination of the pericardial
tissue instead led to a diagnosis of primary pericardial mesothelioma.
Conclusion: Our case demonstrates a pericardial mesothelioma initially masquerading grossly as
pericarditis. Microscopic examination of any grossly abnormal pericardial tissue therefore may be
warranted so that a neoplastic disease process does not go undetected. Additionally, of the
approximately 200 such tumors reported in the medical literature, a case demonstrating marked
hemopericardium and resulting in sudden death has not been described until now.
Background
Fortunately, mesotheliomas are very uncommon tumors,
with an incidence of approximately one per million. Such
lesions arising from the pericardium constitute only 0.7%
of all cases and therefore represent an extremely rare entity
[1]. This neoplasm typically presents insidiously with
rather nonspecific signs and symptoms including dysp-
nea, fever, chest pain, and weight loss. Common clinical
manifestations include constrictive pericarditis, pericar-
dial effusion, cardiac tamponade, and eventual heart fail-
ure usually stemming from either physical compression or
myocardial tumorous infiltration. To date, there are no
reported cases in the medical literature describing a peri-
cardial mesothelioma causing marked hemopericardium,
and resulting in sudden death. Herein, we report such a
case.
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Case Presentation
A 45-year-old African American female presented to the
emergency department (ED) with a new onset of dizzi-
ness, difficulty walking, and low blood pressure. Her past
medical history was significant for hypercholesterolemia,
hypertension, and a recent urinary tract infection. She
smoked tobacco but used neither alcohol nor illegal
drugs. There was no history of asbestos exposure or recent
viral illness. Physical examination was unremarkable. Lab
work was performed and showed normal results, so the
patient was released. The following day, she returned to
the ED once again, and reported that her symptoms had
escalated significantly. Soon thereafter the patient devel-
oped multiple organ failure with subsequent cardiac
arrest, passing into pulseless electrical activity, and her
death was pronounced. The initial significant autopsy
finding was the discovery of approximately one liter of
blood within the pericardial cavity. The pericardial sac
was focally adhesed to the surface of the heart. The peri-
cardial surface of the heart was markedly granular and
thickened. An area on the pericardium of the anterior left
ventricle was focally disrupted without frank tearing or
laceration and blood was observed to ooze through this
defect. Gross photographs were not taken due to the ini-
tial impression of classic pericarditis. The remainder of the
postmortem examination was negative for grossly suspi-
cious malignancy, including pleural, pulmonary and lym-
phoreticular involvement. No abdominal or pelvic
pathology was identified. In particular, there was no
omental or peritoneal caking, and no ovarian, renal, or
hepatic masses were identified. Microscopic examination
of tissue sections taken from the epicardium revealed
dense lymphocytic infiltrates admixed with numerous
neoplastic, polygonal cells with abundant cytoplasm and
enlarged, irregular nuclei containing conspicuous nucle-
oli. Some of these tumor cell clusters formed gland-like
formations and papillary structures (Figure 1). Abundant
necrosis and marked desmoplasia were present. Scattered
karyorrhectic cells were present while mitotic figures were
not identified. There was only mininal tumoral infiltra-
tion into the underlying myocardium. Pericardial calcifi-
cations were not appreciated. Immunohistochemical
stains were performed on the paraffin-embedded epicar-
dial tissue, resulting in marked positivity for pancytokera-
tin, CK5/6 (Figure 2) and calretinin (Figure 3). A
diagnosis of primary pericardial mesothelioma was
thereby confirmed. The cause of death was reported as car-
diac tamponade due to pericarditis due to mesothelioma
of the pericardial sac.
Discussion
Several studies demonstrate the infrequent nature of pri-
mary pericardial mesotheliomas. A ten-year focused
autopsy review of malignant tumors by Mukai, et al.,
recovered a single case out of a total of 2,649 cases while
a larger 500,000 case study provided an incidence of less
than 0.0022% [2,3]. Of the approximately 200 reported
cases in the medical literature, only one of four was diag-
nosed while the patient was still alive [4]. And, in contrast
to pleural mesotheliomas, there is no strong correlation
between pericardial mesothelioma and asbestos exposure.
Perhaps the reason for the lesion's low detection rate
derives from its typical clinical presentation, a group of
nonspecific signs and symptoms of insidious onset related
The epicardial surface shows numerous neoplastic epithelioid  cells Figure 1
The epicardial surface shows numerous neoplastic 
epithelioid cells. In some areas, the tumor cells form gland-
like structures and papillary structures (H&E, ×40).
The cell membranes of the neoplastic cells react strongly and  diffusely with antibodies to CK 5/6 (×100) Figure 2
The cell membranes of the neoplastic cells react 
strongly and diffusely with antibodies to CK 5/6 
(×100). The myocardium can be observed lying just under-
neath the band of neoplastic tissue.Diagnostic Pathology 2009, 4:44 http://www.diagnosticpathology.org/content/4/1/44
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to declining cardiac function - dyspnea, chest pain, fever,
and weight loss - and manifesting as restrictive pericardi-
tis, pericardial effusion, and cardiac tamponade [5]. Local
vascular invasion may result in cerebral ischemia, myocar-
dial infarction, and superior vena cava syndrome [1].
The usually progressive disease process appears to be the
only positive characteristic regarding this tumor, in order
that the patient's condition be diagnosed and afforded at
least some measure of treatment. Unfortunately, the over-
all survival rate is less than six months, and treatment is
focused on palliation, including such procedures as par-
tial pericardectomy for relief of cardiac tamponade [6].
Various chemotherapeutic agents have shown little effi-
cacy; high-dose methotrexate has shown the only
response rate over 20% [7]. Pharmocologic therapies
including lovastatin and a Simian virus 40-based vaccine
(SV40) are still unproven [7]. The authors are unaware of
any data regarding the use of the SV40 vaccine against
pericardial mesotheliomas.
Over the last decade, the SV40 virus has stepped into the
forefront of suspected agents in the pathogenesis of mes-
othelioma [8]. The virus has been shown to cause mes-
othelial tumorigenesis in a number of animal models,
and specific SV40 DNA sequences have been discovered in
malignant pleural mesotheliomas [7]. Carbone, et al.,
report that at least 60% of mesotheliomas in the United
States contain and express SV40, which results in suppres-
sion of tumor suppressors p53 and Rb, thereby leading to
tumor development [9].
The typical gross pathologic features of pericardial mes-
othelioma are that of a tan, variably nodular to solid
thickening of the pericardium, sometimes extending into
the aorta and pulmonary trunk. Epicardial invasion has
been reported, but deep invasion of the myocardium is
not common [1]. Histologically, three different subtypes -
epithelial, sarcomatoid, and mixed (75% of cases) - have
been described.
The usual immunohistochemical positivity of pleural
mesotheliomas for cytokeratin (CK 5/6), calretinin, and
HBME-1 with negative staining for carcinoembryonic
antigen (CEA), B72.3, and Leu-M1, holds true for the peri-
cardial variety. Kayser, et al., discovered that a combina-
tion of probes with antibodies against carrier-
immobilized ganglioside GM1, hyaluronic acid, cal-
retinin, and HBME-1 was highly sensitive and specific for
distinguishing mesothelioma from metastatic carcino-
mas, as the markers for ganglioside GM1 and hyaluronic
acid showed the highest sensitivity and specificity for mes-
othelioma. In contrast, CEA and N-acetyl-D-glucosamine-
bearing neoglycoprotein displayed high sensitivity and
specificity for metastatic carcinomas [10].
In this case, the original diagnosis based upon the gross
examination was that of a diffuse, marked pericarditis
with associated profound hemopericardium. However,
upon initial microscopic examination, while lymphocytic
pericarditis was in fact present, the more significant neo-
plastic entity was additionally identified. Pericarditis,
especially the fibrinous variety, can grossly mimic pericar-
dial mesothelioma, as it may exhibit thickening and a fine
granularity of the pericardium. A host of tumors may also
enter the differential diagnosis. While primary pericardial
neoplasms including angiosarcoma, teratoma, and
fibroma can occur, they are rare also. More commonly
encountered are metastatic tumors originating from lung,
breast, skin (melanoma), as well as lymphomas and
leukemias [11].
When confronted with the finding of hemopericardium
during an autopsy, the forensic pathologist may have a
number of different etiologies to entertain. Altun, et al.,
encountered 40 deaths related to hemopericardium and
concluded that the overwhelming majority of these deaths
were trauma-related [12]. Stabbings accounted for half of
the cases while gunshots and shotgun wounds collectively
comprised approximately 40% of the deaths. Only two
cases were natural demises, although the specific causes of
death were not provided.
Several relatively common causes of hemopericardium
encountered during autopsy include type A aortic dissec-
tions and ruptured myocardial infarctions. A number of
other different etiologies, albeit rare, have been reported
including vascular lesions (angiosarcoma, hemangioma),
anticoagulation therapy, acute bacterial pericarditis, Taka-
yasu aortitis, and rheumatoid arthritis [13-16].
Immunohistochemistry for calretinin displays marked nuclear  and cytoplasmic positivity for the tumor cells (×100) Figure 3
Immunohistochemistry for calretinin displays 
marked nuclear and cytoplasmic positivity for the 
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Conclusion
This challenging autopsy case initially presented as a dif-
fuse, fibrinous pericarditis causing considerable hemo-
pericardium and resulting in sudden death. Histologic
and immunohistochemical analyses were essential in elu-
cidating, and confirming, the presence of a primary peri-
cardial mesothelioma. This case, among others
encountered in our review of the literature, questions the
accuracy of a diagnosis of pericarditis based solely on
gross inspection. Without a microscopic examination of
grossly abnormal pericardial tissue, a more significant dis-
ease process could go undetected. This includes a rare, but
possible, neoplastic process.
Consent
Consent was obtained for publication of this case report
and accompanying images. A copy of the consent is avail-
able for review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
DL constructed the majority of the manuscript. DC pro-
vided the histological interpretations and contributed to
manuscript proofreading. AG provided the case history
and autopsy findings and contributed to manuscript
proofreading.
References
1. Sharaf El-Dean MZ, Bakshi NA, Giraldo AA: Pathologic quiz case:
a patient with Down syndrome presenting with "idiopathic"
pericarditis.  Arch Pathol Lab Med 2004, 128(8):e107-8.
2. Mukai K, Shinkai T, Tominaga K, Shimosato Y: The incidence of
secondary tumors of the heart and pericardium: a 10-year
study.  Jpn J Clin Oncol 1988, 18(3):195-201.
3. Gössinger HD, Siostrzonek P, Zangeneh M, Neuhold A, Herold C,
Schmoliner R, Laczkovics A, Tscholakoff D, Mösslacher H: Mage-
netic resonance imaging findings in a patient with pericardial
mesothelioma.  Am Heart J 1988, 115:1321-2.
4. Suman S, Schofield P, Large S: Primary pericardial mesothelioma
presenting as pericardial constriction: a case report.  Heart
2004, 90(1):e4.
5. Thomason R, Schlegel W, Lucca M, Cummings S, Lee S: Primary
malignant mesothelioma of the pericardium. Case report
and literature review.  Tex Heart Inst J 1994, 21(2):170-4.
6. Santos C, Montesinos J, Castañer E, Sole JM, Baga R: Primary peri-
cardial mesothelioma.  Lung Cancer 2008, 60(2):291-3. Epub 2007
Oct 23
7. Eren NT, Akar AR: Primary pericardial mesothelioma.  Curr
Treat Options Oncol 2002, 3(5):369-73.
8. Rizzo P, Bocchetta M, Powers A, Foddis R, Stekala E, Pass HI, Car-
bone M: SV40 and the pathogenesis of mesothelioma.  Semin
Cancer Biol 2001, 11(1):63-71.
9. Carbone M, Fisher S, Powers A, Pass HI, Rizzo P: New molecular
and epidemiological issues in mesothelioma: role of SV40.  J
Cell Physiol 1999, 180:167-72.
10. Kayser K, Böhm G, Blum S, Beyer M, Zink S, André S, Gabius HJ:
Glyco- and immunohistochemical refinement of the differ-
ential diagnosis between mesothelioma and metastatic car-
cinoma and survival analysis of patients.  J Pathol 2001,
193(2):175-80.
11. Altun G, Altun A, Yilmaz A: Hemopericardium-related fatalities:
a 10-year medicolegal autopsy experience.  Cardiology 2005,
104(3):133-7. Epub 2005 Aug 22
12. Stoupel E, Primo G, Kahn RJ, le Clerc JL, de Wilde P, Deuvaert F,
Toussaint C: Cardiac tamponade with renal failure due to
hemangioma of the heart.  Acta Cardiol 1979, 34(5):345-51.
13. Katis PG: Atraumatic hemopericardium in a patient receiving
warfarin therapy for a pulmonary embolus.  CJEM 2005,
7(3):168-70.
14. Hong YC, Chen YG, Hsiao CT, Kuan JT, Chiu TF, Chen JC: Cardiac
tamponade secondary to haemopericardium in a patient on
warfarin.  Emerg Med J 2007, 24(9):679-80.
15. Olson LJ, Edwards WD, Olney BA, Orszulak TA, Josa M: Hemor-
rhagic cardiac tamponade: a clinicopathologic correlation.
Mayo Clin Proc 1984, 59(11):785-90.
16. Stables RH, Campbell S, Ormerod OJ: Haemopericardium in
rheumatoid arthritis.  Int J Cardiol 1989, 23(2):268-70.